|
1
|
Yi N, Chen SY, Ma A, Chen PS, Yao B, Liang
TM and Liu C: Tunicamycin inhibits PDGF-BB-induced proliferation
and migration of vascular smooth muscle cells through induction of
HO-1. Anat Rec (Hoboken). 295:1462–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang C: MicroRNA-145 in vascular smooth
muscle cell biology: A new therapeutic target for vascular disease.
Cell Cycle. 8:3469–3473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Obata JE, Nakamura T, Kitta Y, Saito Y,
Sano K, Fujioka D, Kawabata K and Kugiyama K: In-stent restenosis
is inhibited in a bare metal stent implanted distal to a
sirolimus-eluting stent to treat a long de novo coronary lesion
with small distal vessel diameter. Catheter Cardiovasc Interv.
82:E777–E787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mazurova VV, Sukhorukov OE and Zakharova
OV: Comparing moderately late results of the application of stents
coated with a medicinal antiproliferative agent for the treatment
of patients with various forms of coronary heart disease: Their
efficacy and safety. Klin Med (Mosk). 90:30–35. 2012.(In Russian).
PubMed/NCBI
|
|
5
|
Moss EG: MicroRNAs: Hidden in the genome.
Curr Biol. 12:R138–R140. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S
and Cong N: MicroRNA-98 acts as a tumor suppressor in
hepatocellular carcinoma via targeting SALL4. Oncotarget.
7:74059–74073. 2016.PubMed/NCBI
|
|
8
|
Yao J, Deng B, Zheng L, Dou L, Guo Y and
Guo K: miR-27b is upregulated in cervical carcinogenesis and
promotes cell growth and invasion by regulating CDH11 and
epithelial-mesenchymal transition. Oncol Rep. 35:1645–1651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen LJ, Lim SH, Yeh YT, Lien SC and Chiu
JJ: Roles of microRNAs in atherosclerosis and restenosis. J Biomed
Sci. 19:792012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weber C, Schober A and Zernecke A:
MicroRNAs in arterial remodelling, inflammation and
atherosclerosis. Curr Drug Targets. 11:950–956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Cheng Y, Zhang S, Lin Y, Yang J and
Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth
muscle cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun SG, Zheng B, Han M, Fang XM, Li HX,
Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Krüppel-like
factor 4 form a feedback loop to participate in vascular smooth
muscle cell proliferation. EMBO Rep. 12:56–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang J, Tao ZH, Wen D, Wan JL, Liu DL,
Zhang S, Cui JF, Sun HC, Wang L, Zhou J, et al: MiR-612 suppresses
the stemness of liver cancer via Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 447:210–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng L, He P, Yang X, Zhou M and Feng Q:
miR-612 negatively regulates colorectal cancer growth and
metastasis by targeting AKT2. Cell Death Dis. 6:e18082015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee J, Lim S, Song BW, Cha MJ, Ham O, Lee
SY, Lee C, Park JH, Bae Y, Seo HH, et al: MicroRNA-29b inhibits
migration and proliferation of vascular smooth muscle cells in
neointimal formation. J Cell Biochem. 116:598–608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li TJ, Chen YL, Gua CJ, Xue SJ, Ma SM and
Li XD: MicroRNA 181b promotes vascular smooth muscle cells
proliferation through activation of PI3K and MAPK pathways. Int J
Clin Exp Pathol. 8:10375–10384. 2015.PubMed/NCBI
|
|
19
|
Kim S and Kang H: miR-15b induced by
platelet-derived growth factor signaling is required for vascular
smooth muscle cell proliferation. BMB Rep. 46:550–554. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gan J, Li P, Wang Z, Chen J, Liang X, Liu
M, Xie W, Yin R and Huang F: Rosuvastatin suppresses
platelet-derived growth factor-BB-induced vascular smooth muscle
cell proliferation and migration via the MAPK signaling pathway.
Exp Ther Med. 6:899–903. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guan S, Tang Q, Liu W, Zhu R and Li B:
Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell
proliferation and migration and attenuates neointimal hyperplasia
in a rat carotid artery injury model. Drug Dev Res. 75:489–496.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frias A, Lambies G, Viñas-Castells R,
Martínez-Guillamon C, Dave N, García de Herreros A and Díaz VM: A
switch in Akt isoforms is required for notch-induced Snail1
expression and protection from cell death. Mol Cell Biol.
36:923–940. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shiratsuchi H and Basson MD: Akt2, but not
Akt1 or Akt3 mediates pressure-stimulated serum-opsonized latex
bead phagocytosis through activating mTOR and p70 S6 kinase. J Cell
Biochem. 102:353–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang W, Zhang X, González-Cobos JC,
Stolwijk JA, Matrougui K and Trebak M: Leukotriene-C4 synthase, a
critical enzyme in the activation of store-independent Orai1/Orai3
channels, is required for neointimal hyperplasia. J Biol Chem.
290:5015–5027. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Borst O, Münzer P, Gatidis S, Schmidt EM,
Schönberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE, et
al: The inflammatory chemokine CXC motif ligand 16 triggers
platelet activation and adhesion via CXC motif receptor 6-dependent
phosphatidylinositide 3-kinase/Akt signaling. Circ Res.
111:1297–1307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rotllan N, Chamorro-Jorganes A, Araldi E,
Wanschel AC, Aryal B, Aranda JF, Goedeke L, Salerno AG, Ramírez CM,
Sessa WC, et al: Hematopoietic Akt2 deficiency attenuates the
progression of atherosclerosis. FASEB J. 29:597–610. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Yan L, Zhang W, Hu N, Chen W, Wang
H, Kang M and Ou H: MicroRNA-21 inhibits platelet-derived growth
factor-induced human aortic vascular smooth muscle cell
proliferation and migration through targeting activator protein-1.
Am J Transl Res. 6:507–516. 2014.PubMed/NCBI
|
|
28
|
Li P, Liu Y, Yi B, Wang G, You X, Zhao X,
Summer R, Qin Y and Sun J: MicroRNA-638 is highly expressed in
human vascular smooth muscle cells and inhibits PDGF-BB-induced
cell proliferation and migration through targeting orphan nuclear
receptor NOR1. Cardiovasc Res. 99:185–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang J, Chen L, Ding J, Fan Z, Li S, Wu H,
Zhang J, Yang C, Wang H, Zeng P and Yang J: MicroRNA-24 inhibits
high glucose-induced vascular smooth muscle cell proliferation and
migration by targeting HMGB1. Gene. 586:268–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC,
Qin LX, Wang L, Zhou J, Ren ZG, Li YX, et al: miR-612 suppresses
the invasive-metastatic cascade in hepatocellular carcinoma. J Exp
Med. 210:789–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
